Literature DB >> 17912531

[Long-term results after pars plana vitrectomy with 25 gauge technique].

A Lommatzsch1, B Heimes, M Trieschmann, G Spital, D Pauleikhoff.   

Abstract

BACKGROUND: The 25-gauge technique of pars plana vitrectomy appears to be a very suitable method, especially for patients with pathological epiretinal alterations of the macula. However, the procedure has been criticized for insufficient impermeability with an increased risk of endophthalmitis and that the flexibility of instruments is too high.
METHOD: Between 2002 and 2006, 625 eyes from 620 patients were operated on using the 25-gauge technique. Epiretinal membranes in different stages had been diagnosed in all patients. The operations were performed by only one surgeon.
RESULTS: The epiretinal membranes were successfully removed in all patients and 329 eyes were analyzed with long-term follow up over 3.1 years. The mean improvement in visual acuity before and after surgery was -0.41 in LogMAR. One week postoperatively normal IOP was observed in all cases. The mean preoperative IOP was 17 mmHg and 8 mmHg 1 day after surgery. In nine patients with postoperative hypotony and choroidal detachment an additional suture was required and seven patients developed a retinal detachment. Endophthalmitis was not observed in any of the patients during the follow-up period.
CONCLUSIONS: The 25-gauge PPV technique appears to be effective and safe for the treatment of epiretinal membranes. The operation has low complication rates with respect to endophthalmitis or retinal detachment. The procedure has recently been further improved by using more stable instruments and better lighting.

Entities:  

Mesh:

Year:  2008        PMID: 17912531     DOI: 10.1007/s00347-007-1629-3

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  26 in total

1.  Sutureless vitrectomy surgery.

Authors:  C H Meyer; E B Rodrigues; J C Schmidt; S Hörle; P Kroll
Journal:  Ophthalmology       Date:  2003-12       Impact factor: 12.079

2.  Endophthalmitis following 25-gauge vitrectomy.

Authors:  S R J Taylor; G W Aylward
Journal:  Eye (Lond)       Date:  2005-11       Impact factor: 3.775

3.  Transconjunctival sutureless 23-gauge vitrectomy.

Authors:  Claus Eckardt
Journal:  Retina       Date:  2005 Feb-Mar       Impact factor: 4.256

4.  [Incidence and prophylaxis of retinal detachment following pars plana vitrectomy].

Authors:  M Rauber; U Mester
Journal:  Ophthalmologe       Date:  2006-08       Impact factor: 1.059

5.  Comparison of visual function after epiretinal membrane removal by 20-gauge and 25-gauge vitrectomy.

Authors:  Kazuaki Kadonosono; Tadashi Yamakawa; Eiichi Uchio; Yasuo Yanagi; Yasuhiro Tamaki; Makoto Araie
Journal:  Am J Ophthalmol       Date:  2006-09       Impact factor: 5.258

6.  Refinements in microinstrumentation for vitreous surgery.

Authors:  E de Juan; D Hickingbotham
Journal:  Am J Ophthalmol       Date:  1990-02-15       Impact factor: 5.258

7.  Sutureless pars plana vitrectomy through self-sealing sclerotomies.

Authors:  J C Chen
Journal:  Arch Ophthalmol       Date:  1996-10

8.  Corneal astigmatic changes after pars plana vitrectomy.

Authors:  H D Jampel; J T Thompson; M Nunez; R G Michels
Journal:  Retina       Date:  1987       Impact factor: 4.256

9.  Vitrectomy: a pars plana approach.

Authors:  R Machemer; H Buettner; E W Norton; J M Parel
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1971 Jul-Aug

10.  [Surgery of idiopathic epimacular membranes. Prognostic factors].

Authors:  A Gaudric; D Cohen
Journal:  J Fr Ophtalmol       Date:  1992       Impact factor: 0.818

View more
  9 in total

1.  [Macular pucker surgery with and without delamination of the internal limiting membrane-a prospective randomized study].

Authors:  M W Storch; M H Khattab; P Lauermann; C Krüger; U Ritzau-Tondrow; R Staudenmaier; J Callizo; H Hoerauf
Journal:  Ophthalmologe       Date:  2019-11       Impact factor: 1.059

Review 2.  [Statement of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on the development, diagnostics and treatment of epiretinal gliosis : Status October 2020].

Authors: 
Journal:  Ophthalmologe       Date:  2021-02       Impact factor: 1.059

3.  Influence of sutureless 23-gauge sclerotomy architecture on postoperative intraocular pressure decrease: results of a multivariate analysis.

Authors:  Rachid Tahiri Joutei Hassani; Mohamed El Sanharawi; Raphael Adam; Claire Monin; Sylvère Dupont-Monod; Christophe Baudouin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-30       Impact factor: 3.117

Review 4.  [Watchful waiting as a therapeutic principle for diseases of the vitreoretinal interface].

Authors:  H Hoerauf; B Kirchhof
Journal:  Ophthalmologe       Date:  2017-11       Impact factor: 1.059

5.  Primary 23-gauge vitreoretinal surgery for rhegmatogenous retinal detachment.

Authors:  Ates Yanyali; Gokhan Celik; Alper Dincyildiz; Fatih Horozoglu; Ahmet F Nohutcu
Journal:  Int J Ophthalmol       Date:  2012-04-18       Impact factor: 1.779

6.  Adverse events after pars plana vitrectomy among medicare beneficiaries.

Authors:  Joshua D Stein; David N Zacks; Daniel Grossman; Hilary Grabe; Mark W Johnson; Frank A Sloan
Journal:  Arch Ophthalmol       Date:  2009-12

7.  Primary 23-gauge sutureless vitrectomy for rhegmatogenous retinal detachment.

Authors:  Mario R Romano; Ronald Das; Carl Groenwald; Theo Stappler; Joaquin Marticorena; Xavier Valldeperas; David Wong; Heinrich Heimann
Journal:  Indian J Ophthalmol       Date:  2012 Jan-Feb       Impact factor: 1.848

Review 8.  Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment.

Authors:  D H W Steel; A J Lotery
Journal:  Eye (Lond)       Date:  2013-10       Impact factor: 3.775

Review 9.  Optimal management of idiopathic macular holes.

Authors:  Haifa A Madi; Ibrahim Masri; David H Steel
Journal:  Clin Ophthalmol       Date:  2016-01-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.